# Reinsurance Group of America Inc: financial statements, quarterly

RGA · NYSE · CIK 898174 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/rga.md) · [Financials](/companies/rga/financials.md) · [Filings](/companies/rga/filings.md) · [Insiders](/companies/rga/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/rga/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [5,153](/filings/0000898174-25-000027.md) | [5,007](/filings/0000898174-25-000027.md) | [6,337](/filings/0000898174-26-000006.md) | [4,878](/filings/0000898174-26-000006.md) | [5,651](/filings/0000898174-26-000006.md) | [5,241](/filings/0000898174-26-000006.md) | [5,260](/filings/0000898174-26-000025.md) | [5,599](/filings/0000898174-26-000034.md) | [6,204](/filings/0000898174-26-000006.md) | [6,635](/filings/0000898174-26-000006.md) | [6,494](/filings/0000898174-26-000025.md) | [6,637](/filings/0000898174-26-000034.md) |
| Interest expense | $m | [72.0](/filings/0000898174-24-000140.md) | [69.0 d](/filings/0000898174-26-000006.md) | [68.0](/filings/0000898174-25-000085.md) | [72.0](/filings/0000898174-25-000130.md) | [78.0](/filings/0000898174-25-000137.md) | [86.0 d](/filings/0000898174-26-000006.md) | [80.0](/filings/0000898174-26-000025.md) | [90.0](/filings/0000898174-26-000034.md) | [98.0](/filings/0000898174-25-000137.md) | [98.0 d](/filings/0000898174-26-000006.md) | [99.0](/filings/0000898174-26-000025.md) | [101](/filings/0000898174-26-000034.md) |
| Income tax | $m | [91.0](/filings/0000898174-24-000140.md) | [4.0 d](/filings/0000898174-26-000006.md) | [60.0](/filings/0000898174-25-000085.md) | [65.0](/filings/0000898174-25-000130.md) | [56.0](/filings/0000898174-25-000137.md) | [75.0 d](/filings/0000898174-26-000006.md) | [81.0](/filings/0000898174-26-000025.md) | [160](/filings/0000898174-26-000034.md) | [65.0](/filings/0000898174-25-000137.md) | [45.0 d](/filings/0000898174-26-000006.md) | [110](/filings/0000898174-26-000025.md) | [141](/filings/0000898174-26-000034.md) |
| Net income | $m | [287](/filings/0000898174-24-000140.md) | [160](/filings/0000898174-25-000027.md) | [210](/filings/0000898174-25-000085.md) | [203](/filings/0000898174-25-000130.md) | [156](/filings/0000898174-25-000137.md) | [150](/filings/0000898174-26-000006.md) | [286](/filings/0000898174-26-000025.md) | [180](/filings/0000898174-26-000034.md) | [253](/filings/0000898174-25-000137.md) | [465](/filings/0000898174-26-000006.md) | [330](/filings/0000898174-26-000025.md) | [462](/filings/0000898174-26-000034.md) |
| Diluted EPS | $ per share | [4.29](/filings/0000898174-25-000027.md) | [2.37](/filings/0000898174-25-000027.md) | [3.16](/filings/0000898174-26-000006.md) | [3.03](/filings/0000898174-26-000006.md) | [2.33](/filings/0000898174-26-000006.md) | [2.22](/filings/0000898174-26-000006.md) | [4.27](/filings/0000898174-26-000025.md) | [2.70](/filings/0000898174-26-000034.md) | [3.81](/filings/0000898174-26-000006.md) | [6.97](/filings/0000898174-26-000006.md) | [4.98](/filings/0000898174-26-000025.md) | [7.01](/filings/0000898174-26-000034.md) |
| Basic EPS | $ per share | [4.34](/filings/0000898174-25-000027.md) | [2.40](/filings/0000898174-25-000027.md) | [3.20](/filings/0000898174-26-000006.md) | [3.07](/filings/0000898174-26-000006.md) | [2.37](/filings/0000898174-26-000006.md) | [2.26](/filings/0000898174-26-000006.md) | [4.33](/filings/0000898174-26-000025.md) | [2.72](/filings/0000898174-26-000034.md) | [3.85](/filings/0000898174-26-000006.md) | [7.07](/filings/0000898174-26-000006.md) | [5.04](/filings/0000898174-26-000025.md) | [7.07](/filings/0000898174-26-000034.md) |

- Revenue: us-gaap:Revenues
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss, us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [2.8](/filings/0000898174-23-000137.md) | [3.0](/filings/0000898174-26-000006.md) | [5.9](/filings/0000898174-24-000097.md) | [4.6](/filings/0000898174-24-000130.md) | [5.2](/filings/0000898174-24-000140.md) | [3.3](/filings/0000898174-26-000006.md) | [5.2](/filings/0000898174-25-000085.md) | [5.4](/filings/0000898174-25-000130.md) | [4.6](/filings/0000898174-25-000137.md) | [4.2](/filings/0000898174-26-000034.md) | [5.0](/filings/0000898174-26-000025.md) | [5.3](/filings/0000898174-26-000034.md) |
| Total assets | $bn | [87.4](/filings/0000898174-23-000137.md) | [97.6](/filings/0000898174-25-000027.md) | [106](/filings/0000898174-24-000097.md) | [110](/filings/0000898174-24-000130.md) | [120](/filings/0000898174-24-000140.md) | [119](/filings/0000898174-26-000006.md) | [128](/filings/0000898174-25-000085.md) | [133](/filings/0000898174-25-000130.md) | [152](/filings/0000898174-25-000137.md) | [157](/filings/0000898174-26-000034.md) | [164](/filings/0000898174-26-000025.md) | [167](/filings/0000898174-26-000034.md) |
| Total liabilities | $bn | [79.3](/filings/0000898174-23-000137.md) | [88.5](/filings/0000898174-25-000027.md) | [96.4](/filings/0000898174-24-000097.md) | [100](/filings/0000898174-24-000130.md) | [109](/filings/0000898174-24-000140.md) | [108](/filings/0000898174-26-000006.md) | [117](/filings/0000898174-25-000085.md) | [121](/filings/0000898174-25-000130.md) | [139](/filings/0000898174-25-000137.md) | [143](/filings/0000898174-26-000034.md) | [151](/filings/0000898174-26-000025.md) | [153](/filings/0000898174-26-000034.md) |
| Long-term debt | $bn | [4.5](/filings/0000898174-23-000137.md) | [4.4](/filings/0000898174-25-000027.md) | [4.4](/filings/0000898174-24-000097.md) | [5.1](/filings/0000898174-24-000130.md) | [5.1](/filings/0000898174-24-000140.md) | [5.0](/filings/0000898174-26-000006.md) | [5.7](/filings/0000898174-25-000085.md) | [5.7](/filings/0000898174-25-000130.md) | [5.7](/filings/0000898174-25-000137.md) | [5.7](/filings/0000898174-26-000034.md) | [6.1](/filings/0000898174-26-000025.md) | [5.7](/filings/0000898174-26-000034.md) |
| Current portion of debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [8.1](/filings/0000898174-24-000140.md) | [9.1](/filings/0000898174-26-000006.md) | [9.5](/filings/0000898174-25-000130.md) | [9.7](/filings/0000898174-25-000137.md) | [11.1](/filings/0000898174-25-000137.md) | [10.8](/filings/0000898174-26-000034.md) | [11.4](/filings/0000898174-26-000034.md) | [12.1](/filings/0000898174-26-000034.md) | [13.0](/filings/0000898174-25-000137.md) | [13.5](/filings/0000898174-26-000034.md) | [13.3](/filings/0000898174-26-000034.md) | [13.7](/filings/0000898174-26-000034.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: not reported
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $bn | [(1.0) d](/filings/0000898174-24-000140.md) | [6.9 d](/filings/0000898174-26-000006.md) | [(5.7)](/filings/0000898174-25-000085.md) | [(1.0) d](/filings/0000898174-25-000130.md) | [(1.1) d](/filings/0000898174-25-000137.md) | [17.1 d](/filings/0000898174-26-000006.md) | [(1.4)](/filings/0000898174-26-000025.md) | [(0.8) d](/filings/0000898174-26-000034.md) | [(1.0) d](/filings/0000898174-25-000137.md) | [7.3 d](/filings/0000898174-26-000006.md) | [(2.9)](/filings/0000898174-26-000025.md) | [(0.5) d](/filings/0000898174-26-000034.md) |
| Capital expenditure | $bn | [0.0 d](/filings/0000898174-23-000137.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Dividends paid | $bn | [0.1 d](/filings/0000898174-24-000140.md) | [0.1 d](/filings/0000898174-26-000006.md) | [0.1](/filings/0000898174-25-000085.md) | [0.1 d](/filings/0000898174-25-000130.md) | [0.1 d](/filings/0000898174-25-000137.md) | [0.1 d](/filings/0000898174-26-000006.md) | [0.1](/filings/0000898174-26-000025.md) | [0.1 d](/filings/0000898174-26-000034.md) | [0.1 d](/filings/0000898174-25-000137.md) | [0.1 d](/filings/0000898174-26-000006.md) | [0.1](/filings/0000898174-26-000025.md) | [0.1 d](/filings/0000898174-26-000034.md) |
| Share repurchases | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [68.0](/filings/0000898174-23-000137.md) | [68.0](/filings/0000898174-24-000097.md) | [68.0](/filings/0000898174-24-000130.md) | [67.0](/filings/0000898174-24-000140.md) | [67.0](/filings/0000898174-25-000085.md) | [67.0](/filings/0000898174-25-000130.md) | [67.0](/filings/0000898174-25-000137.md) | [67.0](/filings/0000898174-26-000025.md) | [67.0](/filings/0000898174-26-000034.md) | [67.0](/filings/0000898174-25-000137.md) | [66.0](/filings/0000898174-26-000025.md) | [66.0](/filings/0000898174-26-000034.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 65,301,665 at 2026-07-28, from the cover of the [10-Q filed 2026-08-07](/filings/0000898174-26-000034.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:27 ET. No prices; not investment advice.